Kristen Favel1,2, Janis M Dionne3,4. 1. Department of Pediatrics, Division of Nephrology, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada. Kristen.Favel@cw.bc.ca. 2. Division of Nephrology, BC Children's Hospital, 4480 Oak Street, Rm K4-153, Vancouver, British Columbia, V6H 3V4, Canada. Kristen.Favel@cw.bc.ca. 3. Department of Pediatrics, Division of Nephrology, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada. 4. BC Renal Agency of the Provincial Health Services Authority, Vancouver, Canada.
Abstract
BACKGROUND: Decision-making in pediatric end-stage renal disease (ESRD) is a complex process for patients, families, and physicians. We evaluated the factors influencing the timing of initiation of renal replacement therapy (RRT) and choice of modality in children with ESRD. METHODS: We retrospectively reviewed the RRT decision-making process for all children up to 19 years of age with ESRD, who underwent RRT over an 11-year period (2004 to 2014), at a Canadian pediatric tertiary care center. RRT modalities included peritoneal dialysis (PD), hemodialysis (HD), pre-emptive kidney transplant (PKT), and continuous renal replacement therapy (CRRT). RESULTS: Ninety-two patients progressed to ESRD. RRT was started electively for 58 patients, and urgently for 34 patients. For elective patients, modalities included PD (34%), HD (19%), and PKT (47%). The glomerular filtration rate at initiation of RRT was higher in patients who underwent PKT as opposed to dialysis (11.7 vs. 9.1 ml/min/1.73m2). Medical and quality of life factors, including fatigue and poor concentration, influenced the timing of initiation of elective RRT. Medical factors were primarily important in urgent RRT, including oligoanuria and metabolic disturbances. Medical factors, patient/family preference, and contextual factors such as location of residence influenced choice of modality. CONCLUSIONS: Our study found that the decision-making process in ESRD is multifactorial and involves not only medical factors, but also assessment of social factors, quality of life, and patient/family preference. Bettering our understanding of this decision-making process will positively impact patients and families through more informed decision-making.
BACKGROUND: Decision-making in pediatric end-stage renal disease (ESRD) is a complex process for patients, families, and physicians. We evaluated the factors influencing the timing of initiation of renal replacement therapy (RRT) and choice of modality in children with ESRD. METHODS: We retrospectively reviewed the RRT decision-making process for all children up to 19 years of age with ESRD, who underwent RRT over an 11-year period (2004 to 2014), at a Canadian pediatric tertiary care center. RRT modalities included peritoneal dialysis (PD), hemodialysis (HD), pre-emptive kidney transplant (PKT), and continuous renal replacement therapy (CRRT). RESULTS: Ninety-two patients progressed to ESRD. RRT was started electively for 58 patients, and urgently for 34 patients. For elective patients, modalities included PD (34%), HD (19%), and PKT (47%). The glomerular filtration rate at initiation of RRT was higher in patients who underwent PKT as opposed to dialysis (11.7 vs. 9.1 ml/min/1.73m2). Medical and quality of life factors, including fatigue and poor concentration, influenced the timing of initiation of elective RRT. Medical factors were primarily important in urgent RRT, including oligoanuria and metabolic disturbances. Medical factors, patient/family preference, and contextual factors such as location of residence influenced choice of modality. CONCLUSIONS: Our study found that the decision-making process in ESRD is multifactorial and involves not only medical factors, but also assessment of social factors, quality of life, and patient/family preference. Bettering our understanding of this decision-making process will positively impact patients and families through more informed decision-making.
Authors: Gihad E Nesrallah; Reem A Mustafa; William F Clark; Adam Bass; Lianne Barnieh; Brenda R Hemmelgarn; Scott Klarenbach; Robert R Quinn; Swapnil Hiremath; Pietro Ravani; Manish M Sood; Louise M Moist Journal: CMAJ Date: 2014-02-04 Impact factor: 8.262
Authors: Bruce A Cooper; Pauline Branley; Liliana Bulfone; John F Collins; Jonathan C Craig; Margaret B Fraenkel; Anthony Harris; David W Johnson; Joan Kesselhut; Jing Jing Li; Grant Luxton; Andrew Pilmore; David J Tiller; David C Harris; Carol A Pollock Journal: N Engl J Med Date: 2010-06-27 Impact factor: 91.245
Authors: Meredith A Atkinson; Pooja C Oberai; Alicia M Neu; Barbara A Fivush; Rulan S Parekh Journal: Pediatr Nephrol Date: 2010-02-27 Impact factor: 3.714
Authors: Nicholas Chesnaye; Marjolein Bonthuis; Franz Schaefer; Jaap W Groothoff; Enrico Verrina; James G Heaf; Augustina Jankauskiene; Viktorija Lukosiene; Elena A Molchanova; Conceicao Mota; Amira Peco-Antić; Ilse-Maria Ratsch; Anna Bjerre; Dimitar L Roussinov; Alexander Sukalo; Rezan Topaloglu; Koen Van Hoeck; Ilona Zagozdzon; Kitty J Jager; Karlijn J Van Stralen Journal: Pediatr Nephrol Date: 2014-07-21 Impact factor: 3.714
Authors: Bikaramjit S Mann; Braden J Manns; Allison Dart; Joanne Kappel; Anita Molzahn; David Naimark; Sharon J Nessim; Steven Soroka; Michael Zappitelli; Manish M Sood Journal: Can J Kidney Health Dis Date: 2014-04-07